(PACB) Pacific Biosciences of - Performance 3.3% in 12m

PACB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating -70.65%
#40 in Peer-Group
Rel. Strength 42.55%
#4260 in Stock-Universe
Total Return 12m 3.33%
#17 in Peer-Group
Total Return 5y -66.84%
#34 in Peer-Group
P/E Value
P/E Trailing -
P/E Forward -
High / Low USD
52 Week High 2.65 USD
52 Week Low 0.91 USD
Sentiment Value
VRO Trend Strength +-100 81.00
Buy/Sell Signal +-5 -1.43
Support / Resistance Levels
Support
Resistance
12m Total Return: PACB (3.3%) vs XLV (-5.4%)
Total Return of Pacific Biosciences of versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (PACB) Pacific Biosciences of - Performance 3.3% in 12m

Top Performer in Life Sciences Tools & Services

Short Term Performance

Symbol 1w 1m 3m
PACB 4.2% 25.6% 5.08%
CTOR 74.0% 389% 368%
NAGE 5.65% 22.9% 109%
PSNL 5.64% 35.8% 86.9%

Long Term Performance

Symbol 6m 12m 5y
PACB -32.2% 3.33% -66.8%
NAGE 171% 436% 218%
PSNL 13.5% 449% -53.8%
CTOR 278% -89.3% -89.3%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
NYSE
Agilent Technologies
6.27% -6.68% 37.4% 29.2 21.2 1.93 45.2% 4.46%
TMO NYSE
Thermo Fisher Scientific
2.37% -24.9% 12.2% 23.8 17.5 1.51 -28.9% -3.66%
IQV NYSE
IQVIA Holdings
13.3% -24.4% 11.4% 21.5 13.4 0.98 56.0% 11.7%
RVTY NYSE
Revvity
8.28% -5.86% -0.14% 39.2 19.3 0.71 -51.9% -36.8%
EKTA-B ST
Elekta (publ)
-1.85% -22.9% -35.5% 77 12.8 1.32 16.6% 1.38%

Performance Comparison: PACB vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PACB
Total Return (including Dividends) PACB XLV S&P 500
1 Month 25.56% 2.04% 4.55%
3 Months 5.08% -7.24% 10.78%
12 Months 3.33% -5.41% 14.71%
5 Years -66.84% 43.58% 112.53%

Trend Score (consistency of price movement) PACB XLV S&P 500
1 Month 79.6% 34.5% 79.2%
3 Months -9.1% -46.5% 92.9%
12 Months -60.5% -71.8% 44.2%
5 Years -75% 87.9% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month %th92.16 23.04% 20.09%
3 Month %th62.75 13.29% -5.14%
12 Month %th72.55 9.25% -9.92%
5 Years %th35.29 -76.91% -84.40%

FAQs

Does Pacific Biosciences of (PACB) outperform the market?

Yes, over the last 12 months PACB made 3.33%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%. Over the last 3 months PACB made 5.08%, while XLV made -7.24%.

Performance Comparison PACB vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

PACB vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 1.3% 21% -38.3% -11%
US NASDAQ 100 QQQ 0.4% 20% -40.4% -12%
German DAX 40 DAX 1.4% 25.6% -51.2% -27%
Shanghai Shenzhen CSI 300 CSI 300 1.6% 21.4% -36.3% -14%
Hongkong Hang Seng HSI 1.7% 19.8% -54% -32%
India NIFTY 50 INDA 1.7% 23.5% -38% 4%
Brasil Bovespa EWZ -0.1% 17.8% -62.8% -10%

PACB vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -0.3% 18.8% -45% -25%
Consumer Discretionary XLY 2.8% 23.9% -29.6% -16%
Consumer Staples XLP 4.7% 27.2% -36.5% -6%
Energy XLE 5.6% 22.1% -32.8% 7%
Financial XLF 1.2% 22.5% -41.4% -26%
Health Care XLV 2.2% 23.5% -31.1% 9%
Industrial XLI 1.7% 21.8% -44.9% -21%
Materials XLB 3.2% 23.9% -37.6% 0%
Real Estate XLRE 5.7% 25.6% -35.7% -9%
Technology XLK -0.1% 16.7% -41.5% -9%
Utilities XLU 3.7% 25.5% -41.7% -21%
Aerospace & Defense XAR -0.7% 15.7% -59.7% -49%
Biotech XBI 3.4% 23.5% -24.3% 14%
Homebuilder XHB 3% 19.5% -27% 3%
Retail XRT 4.3% 24.2% -29.6% -3%

PACB vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 8.5% 20.4% -29.0% 14%
Natural Gas UNG 13.5% 35% -23.1% 11%
Gold GLD 6.2% 27.8% -58.1% -38%
Silver SLV 4.7% 21.7% -56.9% -19%
Copper CPER 1% 21.4% -58% -12%

PACB vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 2.5% 21.9% -35.1% 1%
iShares High Yield Corp. Bond HYG 3.3% 23.7% -37.3% -8%